Lilly's John Lechleiter: Winning back the confidence of people across the spectrum is going to require us to show we can be trusted. The scientific insights we have now are equivalent to being on the road with the lights on rather than trying to feel our way in the dark. We need to show we can translate the revolution in biology to products. And we need to make a lot more moves to restore transparency. Starting in 2009, we're going to make public our payments to physicians. Frankly, we can all do better.
Pfizer's Jeff Kindler: What you have seen from many companies is a willingness to make changes in response to some of the criticism the industry has. We've made commitments about posting our clinical trials, we have supported some legislation that Senator {Charles] Grassley [R-Iowa] has proposed regarding disclosure of certain payments [to doctors]. This is not about words, it's about actions. I like to tell people our business is asking people to put our products in their body. The people we ask to do that are entitled to demand that they [can] trust us. Every day we need to earn that trust.
BusinessWeek
No comments:
Post a Comment